lung cancer cell line
Cytotoxic activity of Androctonus australis hector venom and its toxic fractions on human lung cancer cell line
... Cancer represents a major public health problem and is a leading cause of death worldwide. As reported by International Agency for Research on Cancer (IARC), lung, stomach, liver, colon and breast ...
15
Antifungal potential of punicalagin against Cryptococcus
... human lung cancer cell line, while the hemolytic potential was tested on sheep ...two cell lines showed that punicalagin has low activity on these cells and no activity on sheep ...
6
A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect.
... resistant cell line and characterization of a novel p53 ...H460 lung cancer cell line; radiation resistance was confirmed by clonogenic ...parent cell line, leading ...
10
A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.
... Meanwhile, cell adhesion analysis revealed that Ta1- iRGD exhibited more specific and greater binding with tumor cells compared with ...of cancer cells in vitro, particularly of mouse melanoma cell ...
8
Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells.
... p53-deficient lung cancer cell line H1299 [32] to IR and again assessed MIF ...renal cancer lines and the MCF7 line, MIF secretion was efficiently induced (Fig ...
11
Aqueous Extract of Terminalia chebula Induces Apoptosis in Lung Cancer Cells Via a Mechanism Involving Mitochondria- mediated Pathways
... from Cell Signaling Technology, ...human lung cancer cell line A549 and mouse lung cancer cell line LLC were purchased from Chinese Academy of Sciences ...
8
J. bras. pneumol. vol.39 número1 en v39n1a16
... 10. Asai N, Ohkuni Y, Matsunuma R, Nakashima K, Iwasaki T, Kaneko N. Efficacy and safety of amrubicin for the elderly patients with refractory relapsed small cell lung cancer as third-line ...
3
SINGLE AGENT DOCETAXEL AS SECOND- LINE CHEMOTHERAPY FOR PRETREATED PATIENTS WITH RECURRENT NON- SMALL CELL LUNG CANCER
... second- line agent in the treatment of ...second- line Docetaxel with best supportive care, showing survival prolongation using Docetaxel and a 1- year survival rate of 37%, in line with survival ...
4
Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.
... This study investigated whether SPP, defined here as MST minus MPFS for each trial arm [26,27], has improved substan- tially over the years and to what degree SPP correlates with OS. We showed a steady improvement in SPP ...
8
Cell cycle synchronization and BrdU incorporation as a tool to study the possible selective elimination of ErbB1 gene in the micronuclei in A549 cells
... Lung cancer often exhibits molecular changes, such as the overexpression of the ErbB1 gene that encodes epidermal growth factor receptor ...the cell cycle of A549 cell line (a non-small ...
10
Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.
... in cancer initia- tion and ...many cancer types ...of lung cancer ...with lung cancer risk in never-smoking females ...of lung cancer differs by smoking status. ...
13
Non-Small Cell Lung Cancer: Screening, Diagnosis, and Staging
... Lung cancer is the leading cause of cancer deaths world- ...of lung cancer, accounting for more than 85%90% of all lung cancer ...of lung cancer worldwide, ...
7
BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY
... as cell lines established from human melanoma, pleuramesothelioma and the uteri ...K562 cell lines have been ...gastric cancer cell line (SGC7901), HepG2, A549, HCT116, human ovarian ...
21
Selectins mediate small cell lung cancer systemic metastasis.
... small cell lung cancer (SCLC) ...SCLC line as a model, we found that these cells expressed E- and P-selectin binding sites, which could be in part attributed to the selectin binding ...
11
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
... early-stage lung cancer who have a high baseline lymphocyte-to-monocyte ratio (LMR) have a favorable ...non-small cell lung cancer (NSCLC) receiving first-line epidermal growth ...
13
Defective lung macrophage function in lung cancer ± chronic obstructive pulmonary disease (COPD/emphysema)-mediated by cancer cell production of PGE2?
... of lung and alveolar (AM) macrophages to phagocytose apoptotic cells (defective ‘efferocytosis’), associated with evidence of secondary cellular necrosis and a resultant inflammatory response in the ...in ...
6
CENTRO DE CIÊNCIAS EXATAS E DE TECNOLOGIA DEPARTAMENTO DE QUÍMICA PROGRAMA DE PÓS-GRADUAÇÃO EM QUÍMICA “INFLUÊNCIA DO GRUPO CARBOXÍLICO NA ATIVIDADE
... breast cancer, and A549 – lung cancer) and one normal cell line (Chinese hamster fibroblasts – ...The cell viability after treating the cancer cells with different ...
192
Preparation, characterization, and antiproliferative activities of biotin-decorated docetaxel-loaded bovine serum albumin nanoparticles
... breast cancer cell line), SGC7901 (human gastric carcinoma cell line), LS-174T (human colon adenocarcinoma cell line) and A549 (human lung adenocarcinoma ...
11
Non-Small Cell Lung Cancer: Screening, Diagnosis, and Staging
... Lung cancer is the leading cause of cancer deaths world- ...of lung cancer, accounting for more than 85%90% of all lung cancer ...of lung cancer worldwide, ...
7
Anticancer potential of Azurin interaction with lipid rafts: deciphering the Role of Caveolae
... that cancer cells have the capability of grow, even in the absence of external growth stimulatory signals, frequently by overexpressing growth factor receptor tyrosine kinases (Hanahan and Weinberg, ...in ...
51